Fuller GN - Search Results

1

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.

Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao G. Gressot LV, et al. Among authors: fuller gn. Oncotarget. 2017 Feb 21;8(8):12695-12704. doi: 10.18632/oncotarget.8657. Oncotarget. 2017. PMID: 27074575 Free PMC article.

2

cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines.

Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y, Chen S, Chenchik A, Fuller GN, Zhang W. Rhee CH, et al. Among authors: fuller gn. Oncogene. 1999 Apr 29;18(17):2711-7. doi: 10.1038/sj.onc.1202623. Oncogene. 1999. PMID: 10348345

3

Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.

Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W. Fuller GN, et al. Oncol Rep. 2005 Sep;14(3):651-6. Oncol Rep. 2005. PMID: 16077969

4

Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W. Jiang R, et al. Among authors: fuller gn. Proteomics. 2006 May;6(10):2964-71. doi: 10.1002/pmic.200500555. Proteomics. 2006. PMID: 16619307

5

Insulin-like growth factor binding protein 2 promotes glioma development and progression.

Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W. Dunlap SM, et al. Among authors: fuller gn. Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11736-41. doi: 10.1073/pnas.0703145104. Epub 2007 Jul 2. Proc Natl Acad Sci U S A. 2007. PMID: 17606927 Free PMC article.

6

yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.

Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger AB. Humphries W, et al. Among authors: fuller gn. J Transl Med. 2009 Nov 9;7:92. doi: 10.1186/1479-5876-7-92. J Transl Med. 2009. PMID: 19900287 Free PMC article.

7

Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB. Kong LY, et al. Among authors: fuller gn. Clin Cancer Res. 2010 Dec 1;16(23):5722-33. doi: 10.1158/1078-0432.CCR-10-1693. Epub 2010 Oct 4. Clin Cancer Res. 2010. PMID: 20921210 Free PMC article.

8

Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.

Doucette T, Yang Y, Zhang W, Fuller GN, Suki D, Fults DW, Rao G. Doucette T, et al. Among authors: fuller gn. Int J Cancer. 2011 Nov 1;129(9):2093-103. doi: 10.1002/ijc.25869. Epub 2011 Mar 4. Int J Cancer. 2011. PMID: 21171016 Free PMC article.

9

Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures.

Xu J, Sampath D, Lang FF, Prabhu S, Rao G, Fuller GN, Liu Y, Puduvalli VK. Xu J, et al. Among authors: fuller gn. J Neurooncol. 2011 Nov;105(2):241-51. doi: 10.1007/s11060-011-0604-7. Epub 2011 May 20. J Neurooncol. 2011. PMID: 21598070 Free PMC article.

10

The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.

Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger AB. Lee I, et al. Among authors: fuller gn. Oncotarget. 2012 Mar;3(3):336-44. doi: 10.18632/oncotarget.475. Oncotarget. 2012. PMID: 22488042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters